George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
It's already noted in the RNS on the 22nd :
"We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions."
Three days left!
And RR that was stated in the original RNS as a maximum - I very much doubt they'll get the full amount albeit not impossible it's unlikely particularly when only £5.3m has been received to date.
Hang on - I suggested it could be worth 5x the current price! Some posters here need a reality check.
Everything anyone writes on boards such as these is "IMO" - so never a need to put it in any post.
The Genmab deal is worth nowhere near £600m to the valuation of the business.
That is absolute nonsense of the highest order.
To date £5.3m has been generated in terms of revenue.
The most it could possibly generate in terms of revenue is $624m under a lot of work and cost.
Incrementally you might argue there's somewhere between £50m and £200m if you're very lucky.
I can see a path to a £500m business but even that won't be easy.
Any ideas of £1+ are fantasy in my view and whilst there is the opportunity for great returns from these levels there is likely to be further dilution and challenges at all stages.
I think this is a key moment. Would expect a big move on open tomorrow.
Suspect returns from here will be material - poor decision IMHO.
Yes, that was very positive and the best part of the RNS. Market still not interested.
No - people never look at the numbers or as I noted this morning on another stock - actually read the RNS.
Buyback likely to kick in if that happens
C4XD doing the same. I doubt it will happen with Scancell as funding sorted for a while yet.
The price is the ultimate arbiter and tells you what is going on.
Yes - but we know nothing new about them.
Didn't we learn that in the last update on 17th January?
You didn't have to sell them. You chose to.
"some way off" - can they read? From the RNS - "Our attention is now firmly focussed on drawing the Pensacola farm-out process to a successful conclusion and we look forward to updating the market in due course"
I'll give you a clue - when revenue was £13m they made a loss of £2m so at £34m with the operational gearing they'll be well up and an increase in cash of £8m.
Definitely a "poor investor"
The bid price is now 10.05p - a poor decision to sell if ever I saw one. It was obvious there would be a knee jerk reaction immediately.